Click for best price
Drugs of Bioengineered Protein Market Size, Share 2023
Bioengineered proteins?are synthesized using genetic engineering. They are also called as recombinant?protein.?Bioengineered protein drugs?are used in treatment of human injury, treatment of cancers, hormonal disorders and chronic diseases such as diabetes, asthma, heart disease etc.
This report aims to provide a comprehensive presentation of the global market for Drugs of Bioengineered Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs of Bioengineered Protein. This report contains market size and forecasts of Drugs of Bioengineered Protein in global, including the following market information:
Global Drugs of Bioengineered Protein Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Drugs of Bioengineered Protein market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs of Bioengineered Protein include GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Sanofi, Eli Lilly, Roche, Dr. Reddy's Laboratories and Abbott Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs of Bioengineered Protein companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs of Bioengineered Protein Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Drugs of Bioengineered Protein Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Global Drugs of Bioengineered Protein Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Drugs of Bioengineered Protein Market Segment Percentages, by Application, 2022 (%)
Endocrinology
Immunology
Hematology
Infectiology
Neurology
Oncology
Genetic Disorder
Global Drugs of Bioengineered Protein Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Drugs of Bioengineered Protein Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs of Bioengineered Protein revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drugs of Bioengineered Protein revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis
Sanofi
Eli Lilly
Roche
Dr. Reddy's Laboratories
Abbott Laboratories
Amgen
Bayer AG
Biocon
Fresenius kabi
Panacea Biotec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs of Bioengineered Protein, market overview.
Chapter 2: Global Drugs of Bioengineered Protein market size in revenue.
Chapter 3: Detailed analysis of Drugs of Bioengineered Protein company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs of Bioengineered Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Drugs of Bioengineered Protein Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs of Bioengineered Protein Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs of Bioengineered Protein Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs of Bioengineered Protein Overall Market Size
2.1 Global Drugs of Bioengineered Protein Market Size: 2022 VS 2030
2.2 Global Drugs of Bioengineered Protein Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs of Bioengineered Protein Players in Global Market
3.2 Top Global Drugs of Bioengineered Protein Companies Ranked by Revenue
3.3 Global Drugs of Bioengineered Protein Revenue by Companies
3.4 Top 3 and Top 5 Drugs of Bioengineered Protein Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs of Bioengineered Protein Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs of Bioengineered Protein Players in Global Market
3.6.1 List of Global Tier 1 Drugs of Bioengineered Protein Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs of Bioengineered Protein Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs of Bioengineered Protein Market Size Markets, 2022 & 2030
4.1.2 Monoclonal Antibodies
4.1.3 Therapeutic Proteins
4.1.4 Vaccines
4.2 By Type - Global Drugs of Bioengineered Protein Revenue & Forecasts
4.2.1 By Type - Global Drugs of Bioengineered Protein Revenue, 2018-2023
4.2.2 By Type - Global Drugs of Bioengineered Protein Revenue, 2024-2030
4.2.3 By Type - Global Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs of Bioengineered Protein Market Size, 2022 & 2030
5.1.2 Endocrinology
5.1.3 Immunology
5.1.4 Hematology
5.1.5 Infectiology
5.1.6 Neurology
5.1.7 Oncology
5.1.8 Genetic Disorder
5.2 By Application - Global Drugs of Bioengineered Protein Revenue & Forecasts
5.2.1 By Application - Global Drugs of Bioengineered Protein Revenue, 2018-2023
5.2.2 By Application - Global Drugs of Bioengineered Protein Revenue, 2024-2030
5.2.3 By Application - Global Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Drugs of Bioengineered Protein Market Size, 2022 & 2030
6.2 By Region - Global Drugs of Bioengineered Protein Revenue & Forecasts
6.2.1 By Region - Global Drugs of Bioengineered Protein Revenue, 2018-2023
6.2.2 By Region - Global Drugs of Bioengineered Protein Revenue, 2024-2030
6.2.3 By Region - Global Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Drugs of Bioengineered Protein Revenue, 2018-2030
6.3.2 US Drugs of Bioengineered Protein Market Size, 2018-2030
6.3.3 Canada Drugs of Bioengineered Protein Market Size, 2018-2030
6.3.4 Mexico Drugs of Bioengineered Protein Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Drugs of Bioengineered Protein Revenue, 2018-2030
6.4.2 Germany Drugs of Bioengineered Protein Market Size, 2018-2030
6.4.3 France Drugs of Bioengineered Protein Market Size, 2018-2030
6.4.4 U.K. Drugs of Bioengineered Protein Market Size, 2018-2030
6.4.5 Italy Drugs of Bioengineered Protein Market Size, 2018-2030
6.4.6 Russia Drugs of Bioengineered Protein Market Size, 2018-2030
6.4.7 Nordic Countries Drugs of Bioengineered Protein Market Size, 2018-2030
6.4.8 Benelux Drugs of Bioengineered Protein Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Drugs of Bioengineered Protein Revenue, 2018-2030
6.5.2 China Drugs of Bioengineered Protein Market Size, 2018-2030
6.5.3 Japan Drugs of Bioengineered Protein Market Size, 2018-2030
6.5.4 South Korea Drugs of Bioengineered Protein Market Size, 2018-2030
6.5.5 Southeast Asia Drugs of Bioengineered Protein Market Size, 2018-2030
6.5.6 India Drugs of Bioengineered Protein Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Drugs of Bioengineered Protein Revenue, 2018-2030
6.6.2 Brazil Drugs of Bioengineered Protein Market Size, 2018-2030
6.6.3 Argentina Drugs of Bioengineered Protein Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs of Bioengineered Protein Revenue, 2018-2030
6.7.2 Turkey Drugs of Bioengineered Protein Market Size, 2018-2030
6.7.3 Israel Drugs of Bioengineered Protein Market Size, 2018-2030
6.7.4 Saudi Arabia Drugs of Bioengineered Protein Market Size, 2018-2030
6.7.5 UAE Drugs of Bioengineered Protein Market Size, 2018-2030
7 Drugs of Bioengineered Protein Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Drugs of Bioengineered Protein Major Product Offerings
7.1.4 GlaxoSmithKline Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Drugs of Bioengineered Protein Major Product Offerings
7.2.4 Johnson & Johnson Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Drugs of Bioengineered Protein Major Product Offerings
7.3.4 Merck Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Drugs of Bioengineered Protein Major Product Offerings
7.4.4 Novartis Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Drugs of Bioengineered Protein Major Product Offerings
7.5.4 Sanofi Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Company Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Drugs of Bioengineered Protein Major Product Offerings
7.6.4 Eli Lilly Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.6.5 Eli Lilly Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Drugs of Bioengineered Protein Major Product Offerings
7.7.4 Roche Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 Dr. Reddy's Laboratories
7.8.1 Dr. Reddy's Laboratories Company Summary
7.8.2 Dr. Reddy's Laboratories Business Overview
7.8.3 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Major Product Offerings
7.8.4 Dr. Reddy's Laboratories Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.8.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Company Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Drugs of Bioengineered Protein Major Product Offerings
7.9.4 Abbott Laboratories Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.9.5 Abbott Laboratories Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Drugs of Bioengineered Protein Major Product Offerings
7.10.4 Amgen Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.10.5 Amgen Key News & Latest Developments
7.11 Bayer AG
7.11.1 Bayer AG Company Summary
7.11.2 Bayer AG Business Overview
7.11.3 Bayer AG Drugs of Bioengineered Protein Major Product Offerings
7.11.4 Bayer AG Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.11.5 Bayer AG Key News & Latest Developments
7.12 Biocon
7.12.1 Biocon Company Summary
7.12.2 Biocon Business Overview
7.12.3 Biocon Drugs of Bioengineered Protein Major Product Offerings
7.12.4 Biocon Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.12.5 Biocon Key News & Latest Developments
7.13 Fresenius kabi
7.13.1 Fresenius kabi Company Summary
7.13.2 Fresenius kabi Business Overview
7.13.3 Fresenius kabi Drugs of Bioengineered Protein Major Product Offerings
7.13.4 Fresenius kabi Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.13.5 Fresenius kabi Key News & Latest Developments
7.14 Panacea Biotec
7.14.1 Panacea Biotec Company Summary
7.14.2 Panacea Biotec Business Overview
7.14.3 Panacea Biotec Drugs of Bioengineered Protein Major Product Offerings
7.14.4 Panacea Biotec Drugs of Bioengineered Protein Revenue in Global Market (2018-2023)
7.14.5 Panacea Biotec Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs of Bioengineered Protein Market Opportunities & Trends in Global Market
Table 2. Drugs of Bioengineered Protein Market Drivers in Global Market
Table 3. Drugs of Bioengineered Protein Market Restraints in Global Market
Table 4. Key Players of Drugs of Bioengineered Protein in Global Market
Table 5. Top Drugs of Bioengineered Protein Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs of Bioengineered Protein Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs of Bioengineered Protein Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs of Bioengineered Protein Product Type
Table 9. List of Global Tier 1 Drugs of Bioengineered Protein Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs of Bioengineered Protein Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs of Bioengineered Protein Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Drugs of Bioengineered Protein Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs of Bioengineered Protein Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Drugs of Bioengineered Protein Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Drugs of Bioengineered Protein Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs of Bioengineered Protein Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Drugs of Bioengineered Protein Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Drugs of Bioengineered Protein Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs of Bioengineered Protein Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs of Bioengineered Protein Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs of Bioengineered Protein Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs of Bioengineered Protein Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs of Bioengineered Protein Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs of Bioengineered Protein Revenue, (US$, Mn), 2024-2030
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Drugs of Bioengineered Protein Product Offerings
Table 32. GlaxoSmithKline Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Drugs of Bioengineered Protein Product Offerings
Table 36. Johnson & Johnson Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Drugs of Bioengineered Protein Product Offerings
Table 40. Merck Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Drugs of Bioengineered Protein Product Offerings
Table 44. Novartis Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Drugs of Bioengineered Protein Product Offerings
Table 48. Sanofi Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Eli Lilly Company Summary
Table 51. Eli Lilly Drugs of Bioengineered Protein Product Offerings
Table 52. Eli Lilly Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 53. Eli Lilly Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Drugs of Bioengineered Protein Product Offerings
Table 56. Roche Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Dr. Reddy's Laboratories Company Summary
Table 59. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Product Offerings
Table 60. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 61. Dr. Reddy's Laboratories Key News & Latest Developments
Table 62. Abbott Laboratories Company Summary
Table 63. Abbott Laboratories Drugs of Bioengineered Protein Product Offerings
Table 64. Abbott Laboratories Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 65. Abbott Laboratories Key News & Latest Developments
Table 66. Amgen Company Summary
Table 67. Amgen Drugs of Bioengineered Protein Product Offerings
Table 68. Amgen Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 69. Amgen Key News & Latest Developments
Table 70. Bayer AG Company Summary
Table 71. Bayer AG Drugs of Bioengineered Protein Product Offerings
Table 72. Bayer AG Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 73. Bayer AG Key News & Latest Developments
Table 74. Biocon Company Summary
Table 75. Biocon Drugs of Bioengineered Protein Product Offerings
Table 76. Biocon Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 77. Biocon Key News & Latest Developments
Table 78. Fresenius kabi Company Summary
Table 79. Fresenius kabi Drugs of Bioengineered Protein Product Offerings
Table 80. Fresenius kabi Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 81. Fresenius kabi Key News & Latest Developments
Table 82. Panacea Biotec Company Summary
Table 83. Panacea Biotec Drugs of Bioengineered Protein Product Offerings
Table 84. Panacea Biotec Drugs of Bioengineered Protein Revenue (US$, Mn) & (2018-2023)
Table 85. Panacea Biotec Key News & Latest Developments
List of Figures
Figure 1. Drugs of Bioengineered Protein Segment by Type in 2022
Figure 2. Drugs of Bioengineered Protein Segment by Application in 2022
Figure 3. Global Drugs of Bioengineered Protein Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs of Bioengineered Protein Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Drugs of Bioengineered Protein Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs of Bioengineered Protein Revenue in 2022
Figure 8. By Type - Global Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
Figure 9. By Application - Global Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
Figure 10. By Type - Global Drugs of Bioengineered Protein Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
Figure 12. By Application - Global Drugs of Bioengineered Protein Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
Figure 14. By Region - Global Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
Figure 15. By Country - North America Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
Figure 16. US Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
Figure 20. Germany Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 21. France Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
Figure 28. China Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 32. India Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
Figure 34. Brazil Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Drugs of Bioengineered Protein Revenue Market Share, 2018-2030
Figure 37. Turkey Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Drugs of Bioengineered Protein Revenue, (US$, Mn), 2018-2030
Figure 41. GlaxoSmithKline Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eli Lilly Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Roche Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Dr. Reddy's Laboratories Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Abbott Laboratories Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Amgen Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bayer AG Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Biocon Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Fresenius kabi Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Panacea Biotec Drugs of Bioengineered Protein Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
